Factory direct supply antiviral agent 99% Arbidol cas131707-25-0
GMP ISO
131707-25-0
Pharmaceutical Grade
99.75%
beijing
Million
1g 10g 100g 1kg/bag 25kg/Cardboard Drum
2065-06-12
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceUmifenovir is an indolyl carboxylic acid.|Umifenovir is an indole-based, hydrophobic, dual-acting direct antiviral/host-targeting agent used for the treatment and prophylaxis of influenza and other respiratory infections. It has been in use in Russia for approximately 25 years and in China since 2006. Its invention is credited to a collaboration between Russian scientists from several research institutes 40-50 years ago, and reports of its chemical synthesis date back to 1993. Umifenovir's ability to exert antiviral effects through multiple pathways has resulted in considerable investigation into its use for a variety of enveloped and non-enveloped RNA and DNA viruses, including Flavivirus, Zika virus, foot-and-mouth disease, Lassa virus, Ebola virus, herpes simplex,, hepatitis B and C viruses, chikungunya virus, reovirus, Hantaan virus, and coxsackie virus B5. This dual activity may also confer additional protection against viral resistance, as the development of resistance to umifenovir does not appear to be significant. Umifenovir is currently being investigated as a potential treatment and prophylactic agent for COVID-19 caused by SARS-CoV2 infections in combination with both currently available and investigational HIV therapies.|Umifenovir is an orally bioavailable indole derivative, with broad-spectrum antiviral and potential anti-inflammatory activities. Upon oral administration, umifenovir inhibits the fusion of the viral envelope with host cell membrane, thereby blocking the entry of virus into host cells and preventing viral infection and replication. Umifenovir may also suppress the expression of the cytokines interleukin-1beta (IL-1b), IL-6, IL-12 and tumor necrosis factor-alpha (TNF-a) and promote the expression of IL-10. This may reduce inflammation.CertificatesBasic Info
-
Product Name:
Ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate
Other Name:1H-Indole-3-carboxylic acid,6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-,ethyl ester;Ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate;Umifenovir;BRD 1242
CAS No.:131707-25-0
Molecular Formula:C22H25BrN2O3S
InChIKeys:InChIKey=KCFYEAOKVJSACF-UHFFFAOYSA-N
Molecular Weight:531.89
Exact Mass:477.41
EC Number:1312995-182-4
UNII:93M09WW4RU
NCI Thesaurus Code:C152799
ATC Code:J - Antiinfectives for systemic use
Categories:
Characteristics-
PSA:
80
XLogP3:4.4
Appearance:White to off-white crystalline powder
Density:1.37±0.1 g/cm3(Predicted)
Boiling Point:591.8±50.0 °C(Predicted)
Flash Point:311.7±30.1 °C
Refractive Index:1.620
Water Solubility:"Expected to be poorly soluble"
Vapor Pressure:1.34E-14mmHg at 25°C
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
Certifications:
business license
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
